Request Deal Involvement

Vitrolife completed the acquisition of Igenomix from EQT Partners for $1.48bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Allen & Overy

legal advisors

Allen & Overy

Freshfields Bruckhaus Deringer

legal advisors

Freshfields Bruckhaus Deringer

White & Case

legal advisors

White & Case

JP Morgan

financial advisors

JP Morgan

Morgan Stanley

financial advisors

Morgan Stanley

Jamieson

financial advisors

Jamieson

Garrigues

legal advisors

Garrigues

Allen & Overy

legal advisors

Allen & Overy

Grupo Albion

pr advisors

Grupo Albion

Kekst CNC

pr advisors

Kekst CNC

Dentons

legal advisors

Dentons

SEB Corporate Finance

financial advisors

SEB Corporate Finance

Lazard

financial advisors

Lazard

Nordea Bank

debt providers

Nordea Bank

SEB Corporate Finance

brokers

SEB Corporate Finance

Cedric

legal advisors

Cedric

Araoz & Rueda

legal advisors

Araoz & Rueda

or

Principals

IGENOMIX

target

IGENOMIX

EQT PARTNERS AB

vendor

EQT PARTNERS AB

VITROLIFE

bidder

VITROLIFE

CHARME CAPITAL PARTNERS SGR SPA

vendor

CHARME CAPITAL PARTNERS SGR SPA

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Vitrolife completed the acquisition of Igenomix from EQT Partners for $1.48bn.